Assia Belgacem

Assia Belgacem is a seasoned professional in regulatory affairs with extensive experience across various pharmaceutical and biotechnological sectors. Currently serving as a Regulatory Affairs Senior Consultant at PolyPeptide Group since March 2023, Assia provides scientific leadership and authors critical regulatory documents in compliance with EMA and FDA guidelines. Prior experience includes leadership roles at Novartis from 2016 to 2023, where Assia oversaw regulatory affairs for multiple therapeutic areas and maintained strong relationships with health authorities. A background in market access and regulatory affairs at Bayer Pharmaceuticals complements expertise in managing stakeholder relationships and developing regulatory strategies. Assia holds advanced degrees in Pharmacy and Business from esteemed institutions, including a Pharm.D from Algiers University of Medicine, an MBA from ESG Paris Business School, and specialized certificates from MIT and Novartis.